joe rogan peptides bpc 157 Is Right About BPC-157? FDA panel narrowly backs peptide

If reticulocytes have not increased after treatment or if reticulocyte counts do not continue at least twice normal as long as the hematocrit is less than 35%, diagnosis or treatment should be reevaluated

279(3):E501 to 507

The honest answer is that it depends on the indication, and the timeline varies enough between tissue types that a single number is misleading

Weight reduction: Clinical trials report substantial bodyweight loss (up to ~11 kg more than GLP1 RA comparators over 26 weeks at higher doses) [3] [4]

For peptides with short half-lives (under 2 hours), the route choice has more significant implications for research outcomes